What is the value of supplementary prescribing in the 2020s? A dietitian's perspective

Journal article


Ruddock, N. and Rees, S. (2022). What is the value of supplementary prescribing in the 2020s? A dietitian's perspective. Journal of Prescribing Practice. 4 (5), pp. 194-199. https://doi.org/10.12968/jprp.2022.4.5.194
AuthorsRuddock, N. and Rees, S.
AbstractBackground Non-medical prescribing is well-established in healthcare. Two models are used in practice: supplementary prescribing and independent prescribing. Supplementary prescribing incorporates higher levels of supervision and governance and is the model permitted for use by dietitians. Aim To explore the value of supplementary prescribing from a dietitian's perspective. Method Non-medical prescribing models will be evaluated to establish the benefits and drawbacks of each and discussed in relation to dietetic practice. Results Both models of prescribing are perceived positively by patients. Training for both models is identical and enables the practitioner to work within their scope of practice. However, the clinical management plan, necessary for supplementary prescribing, is limiting and can prevent practitioners from implementing their role efficiently. Conclusions Supplementary prescribing has allowed dietitians to begin prescribing, but for other professions, this model has been superseded by independent prescribing. Supplementary prescribing may be becoming redundant in the 2020s.
KeywordsPharmacology (medical); Pharmacology (nursing)
Year2022
JournalJournal of Prescribing Practice
Journal citation4 (5), pp. 194-199
PublisherMark Allen Group
ISSN2631-8385
2631-8393
Digital Object Identifier (DOI)https://doi.org/10.12968/jprp.2022.4.5.194
Publication dates
Online13 May 2022
Publication process dates
Accepted02 May 2022
Deposited08 Jun 2022
Additional information

This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Prescribing Practice, copyright © MA Healthcare, after peer review and technical editing by the publisher. To access the final edited and published work see https://www.magonlinelibrary.com/doi/full/10.12968/jprp.2022.4.5.194

Permalink -

https://openresearch.lsbu.ac.uk/item/8zz1q

Restricted files

Accepted author manuscript

  • 9
    total views
  • 0
    total downloads
  • 9
    views this month
  • 0
    downloads this month

Export as

Related outputs

A warfarin-antibiotic drug-drug interaction
Feeney, S., Rees, S. and Modha, R.K. (2022). A warfarin-antibiotic drug-drug interaction. Journal of Prescribing Practice. 4 (4), pp. 156-159. https://doi.org/10.12968/jprp.2022.4.4.156SectionsPDF/EPUB
Quetiapine
Rees, S. (2022). Quetiapine. Journal of Prescribing Practice. 4 (3), pp. 96-96. https://doi.org/10.12968/jprp.2022.4.3.96
ALLOPURINOL
Rees, Sharon (2022). ALLOPURINOL. Journal of Prescribing Practice. 4 (2), pp. 51-51. https://doi.org/10.12968/jprp.2022.4.2.51
NYSTATIN
Rees, S. (2022). NYSTATIN. Journal of Prescribing Practice. 4 (1), pp. 8-8. https://doi.org/10.12968/jprp.2022.4.1.8
CLOPIDOGREL
Rees, Sharon (2021). CLOPIDOGREL. Journal of Prescribing Practice. 3 (12), pp. 474-475. https://doi.org/10.12968/jprp.2021.3.12.474
Sertraline
Rees, S. (2021). Sertraline. Journal of Prescribing Practice. 3 (11), pp. 436-436. https://doi.org/10.12968/jprp.2021.3.11.436
ALENDRONIC ACID
Rees, S. (2021). ALENDRONIC ACID. Journal of Prescribing Practice. 3 (10), pp. 386-386. https://doi.org/10.12968/jprp.2021.3.10.386
DEXAMETHASONE
Rees, S. (2021). DEXAMETHASONE. Journal of Prescribing Practice. 3 (9), pp. 342-342. https://doi.org/10.12968/jprp.2021.3.9.342
Memantine
Rees, S. (2021). Memantine. Journal of Prescribing Practice. 3 (8), pp. 298-298. https://doi.org/10.12968/jprp.2021.3.8.298
Ciprofloxacin
Rees, S. (2021). Ciprofloxacin. Journal of Prescribing Practice. 3 (7), pp. 254-255. https://doi.org/10.12968/jprp.2021.3.7.254
RIVAROXABAN
Rees, S. (2021). RIVAROXABAN. Journal of Prescribing Practice. 3 (6), pp. 210-212. https://doi.org/10.12968/jprp.2021.3.6.210
DAPAGLIFLOZIN
Rees, S. (2021). DAPAGLIFLOZIN. Journal of Prescribing Practice. 3 (5), pp. 166-166. https://doi.org/10.12968/jprp.2021.3.5.166
AZT / ABACAVIR
Rees, S. (2021). AZT / ABACAVIR. Journal of Prescribing Practice. 3 (4), pp. 132-132. https://doi.org/10.12968/jprp.2021.3.4.132
TAMOXIFEN
Rees, S. (2021). TAMOXIFEN. Journal of Prescribing Practice. 3 (3), pp. 96-96. https://doi.org/10.12968/jprp.2021.3.3.96
THEOPHYLLINE
Rees, S. (2021). THEOPHYLLINE. Journal of Prescribing Practice. 3 (2), pp. 52-52. https://doi.org/10.12968/jprp.2021.3.2.52
Drug Breakdown: CARBAMAZEPINE
Rees, Sharon (2021). Drug Breakdown: CARBAMAZEPINE. Journal of Prescribing Practice. 3 (1), pp. 8-9. https://doi.org/10.12968/jprp.2021.3.1.8
FLUCONAZOLE
Rees, S. (2020). FLUCONAZOLE. Journal of Prescribing Practice. 2 (12), pp. 657-657. https://doi.org/10.12968/jprp.2020.2.12.657
DABIGATRAN
Rees, S. (2020). DABIGATRAN. Journal of Prescribing Practice. 2 (11), pp. 564-565. https://doi.org/10.12968/jprp.2020.2.11.564
Drug Breakdown Nitrofurantoin
Rees, S. (2020). Drug Breakdown Nitrofurantoin. Journal of Prescribing Practice. 2 (10). https://doi.org/10.12968/jprp.2020.2.10.526
7 Days of Haloperidol
Rees, S. (2020). 7 Days of Haloperidol. Journal of Prescribing Practice. 2 (9). https://doi.org/10.12968/jprp.2020.2.9.476
Furosemide
Rees, S. (2020). Furosemide. Journal of Prescribing Practice. 2 (4), p. 165. https://doi.org/10.12968/jprp.2020.2.4.165
7 days of mercaptopurine
Rees, S. (2020). 7 days of mercaptopurine. Journal of Prescribing Practice. 2 (1). https://doi.org/10.12968/jprp.2020.2.1.6
7 days of doxycycline
Rees, S. (2020). 7 days of doxycycline. Journal of Prescribing Practice. 2 (5), p. 216. https://doi.org/10.12968/jprp.2020.2.5.216
7 days of hydroxychloroquine
Rees, S. (2020). 7 days of hydroxychloroquine . Journal of Prescribing Practice. 2 (6), p. 268. https://doi.org/10.12968/jprp.2020.2.6.268
CYCLIZINE
Rees, Sharon (2020). CYCLIZINE. Journal of Prescribing Practice. 2 (8), pp. 424-424. https://doi.org/10.12968/jprp.2020.2.8.424
Glyceryl Trinitrate
Rees, S. (2020). Glyceryl Trinitrate. Journal of Prescribing Practice. 2 (7), pp. 372-373. https://doi.org/10.12968/jprp.2020.2.7.372
Sprionolactone
Rees, S. (2019). Sprionolactone. Journal of Prescribing Practice. 1 (12), p. 579. https://doi.org/10.12968/jprp.2019.1.12.579
Higher degrees in nursing: traditional research PhD or professional doctorate?
Rees, S., Ousey, K., Koo, K., Ahmad, N. and Bowling, F. (2019). Higher degrees in nursing: traditional research PhD or professional doctorate? British Journal of Nursing. 28 (14), pp. 940-945. https://doi.org/10.12968/bjon.2019.28.14.940
Drug therapies to manage nausea and vomiting
Rees, SM (2018). Drug therapies to manage nausea and vomiting. Nurse Prescribing. 16 (1), pp. 37-44. https://doi.org/10.12968/npre.2018.16.1.37
Local Antibiotic Delivery Systems: Current and Future Applications for Diabetic Foot Infections.
Markakis, K, Faris, AR, Sharaf, H, Faris, B, Rees, SM and Bowling, FL (2018). Local Antibiotic Delivery Systems: Current and Future Applications for Diabetic Foot Infections. International Journal of Lower Extremity Wounds. 17 (1), pp. 14-21. https://doi.org/10.1177/1534734618757532
Barriers to implementing the Sepsis Six guidelines in an acute hospital setting
Breen, SJ and Rees, SM (2018). Barriers to implementing the Sepsis Six guidelines in an acute hospital setting. British Journal of Nursing. 27 (9), pp. 473-478. https://doi.org/10.12968/bjon.2018.27.9.473
Gabapentin and pregabalin in the pain setting: all you need to know
Rees, SM (2018). Gabapentin and pregabalin in the pain setting: all you need to know. Nurse Prescribing. 16 (7). https://doi.org/10.12968/npre.2018.16.7.332
A practical guide to prescribing statins in primary care
Rees, SM (2018). A practical guide to prescribing statins in primary care. Practice Nursing. 29 (8). https://doi.org/10.12968/pnur.2018.29.8.377
Buprenorphine—an atypical opioid: All you need to know
Rees, SM (2017). Buprenorphine—an atypical opioid: All you need to know. Nurse Prescribing. 15 (8), pp. 402-408. https://doi.org/10.12968/npre.2017.15.8.402